Business
Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025
Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture and Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed th
About this update from Cibus, Inc.
[{"type":"image","alt":"Cibus US LLC","displaySize":"","headline":null,"caption":"Cibus US LLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":73,"url":"https://media.zenfs.com/en/globenewswire.com/58c1559c286a019e93de2b224f0b2cca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/x8BgYShLyeeVv2BmS1JaDQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/58c1559c286a019e93de2b224f0b2cca","width":300,"height":73}},"lazy":false},{"type":"text","content":"Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets","length":284,"tagName":"p"},{"type":"text","content":"Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture and Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed through conventional breeding","length":254,"tagName":"p"},{"type":"text","content":"Disease resistance program advances with positive Sclerotinia data for multiple modes of action against Sclerotinia in Canola; Cibus' time bound and predictable RTDS technologies enabling novel approach to combating yield losses and generating significant commercial interest","length":279,"tagName":"p"},{"type":"text","content":"USDA-APHIS designates Canola disease resistance traits as not regulated; Confirmation validates US regulatory treatment of Cibus' RTDS technologies and strengthens commercial pathway","length":186,"tagName":"p"},{"type":"text","content":"First quarter also saw the EU member states endorse the EU Council's negotiating mandate on the regulation of plants obtained by New Genomic Techniques (NGTs), enabling trilogue discussions (EU Parliament, Commission, and Council) on the text of the legislation to be proposed for final adoption","length":299,"tagName":"p"},{"type":"text","content":"SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today annou...